Phibro Animal Health Corp. (PAHC)
35.31
-1.01
(-2.78%)
USD |
NASDAQ |
Aug 24, 16:00
35.36
+0.05
(+0.14%)
After-Hours: 20:00
Phibro Animal Health Shareholders Equity (Quarterly) : 361.83M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 361.83M |
| December 31, 2025 | 332.36M |
| September 30, 2025 | 311.68M |
| June 30, 2025 | 285.68M |
| March 31, 2025 | 265.99M |
| December 31, 2024 | 246.80M |
| September 30, 2024 | 258.53M |
| June 30, 2024 | 256.64M |
| March 31, 2024 | 270.09M |
| December 31, 2023 | 270.80M |
| September 30, 2023 | 273.07M |
| June 30, 2023 | 282.51M |
| March 31, 2023 | 272.33M |
| December 31, 2022 | 268.37M |
| September 30, 2022 | 262.76M |
| June 30, 2022 | 262.44M |
| March 31, 2022 | 266.94M |
| December 31, 2021 | 239.29M |
| September 30, 2021 | 233.30M |
| June 30, 2021 | 238.53M |
| March 31, 2021 | 215.92M |
| December 31, 2020 | 213.32M |
| September 30, 2020 | 192.41M |
| June 30, 2020 | 188.20M |
| March 31, 2020 | 195.34M |
| Date | Value |
|---|---|
| December 31, 2019 | 217.42M |
| September 30, 2019 | 206.69M |
| June 30, 2019 | 216.02M |
| March 31, 2019 | 213.72M |
| December 31, 2018 | 205.22M |
| September 30, 2018 | 192.06M |
| June 30, 2018 | 184.95M |
| March 31, 2018 | 185.54M |
| December 31, 2017 | 168.32M |
| September 30, 2017 | 169.48M |
| June 30, 2017 | 151.16M |
| March 31, 2017 | 139.41M |
| December 31, 2016 | 112.61M |
| September 30, 2016 | 102.28M |
| June 30, 2016 | 90.48M |
| March 31, 2016 | 77.70M |
| December 31, 2015 | 53.31M |
| September 30, 2015 | 22.60M |
| June 30, 2015 | 29.63M |
| March 31, 2015 | 23.08M |
| December 31, 2014 | 26.04M |
| September 30, 2014 | 21.61M |
| June 30, 2014 | 15.15M |
| March 31, 2014 | -78.72M |
| December 31, 2013 | -63.53M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Zoetis, Inc. | 3.148B |
| Merck & Co., Inc. | 41.93B |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.445B |
| Total Liabilities (Quarterly) | 1.083B |
| Debt to Equity Ratio | 2.176 |
| Current Ratio | 3.172 |
| Net Debt Paydown Yield | 0.02% |